Pollack thanks staff for advancing Cornell’s mission

In her annual Address to Staff on Jan. 11 – Ezra Cornell’s 216th birthday – President Martha E. Pollack highlighted achievements that are helping to sustain and re-imagine the university’s founding “… any person … any study” vision.

Mapping brain repair and remodeling after stroke

Researchers at Weill Cornell Medicine have catalogued the cellular response to stroke in a preclinical model, identifying the immune cells involved and the roles they may play in the days and weeks following a stroke.

Grant to validate blood test for early breast cancer detection

Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to evaluate a test that uses an artificial intelligence algorithm to determine whether a patient is positive for cancer.

Grants will fund tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis drug development.

3D organization of DNA controls cell identity programs

A new study reveals that beyond providing a convenient way to store DNA in a tight space, the 3D organization of noncoding gene regulators in chromatin contributes to the control of key cell identity programs in early embryonic development.

Aggressive colon tumor may be vulnerable to cholesterol therapy

A preclinical study has shown that colorectal pre-cancerous lesions known as serrated polyps, and the aggressive tumors that develop from them, depend on the ramped-up production of cholesterol, which points to the possibility of using cholesterol-lowering drugs to prevent or treat such tumors.

The Dead rise: Cornell '77 tribute show among top stories of 2023

When Dead & Company came to Cornell in May for a benefit concert commemorating the Grateful Dead’s famed “Cornell ’77” show, it drew thousands to Barton Hall. The March announcement of the show was the most-viewed Chronicle story of 2023.

Discontinuing anti-obesity drug tirzepatide leads to weight regain

A clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found remaining on the anti-obesity drug tirzepatide promoted additional weight loss and preserved improvements in metabolic and cardiovascular health.

Team designing digital health tools for pregnant refugees wins NAM prize

An intercampus collaboration that aims to provide digital health care tools to pregnant refugee women, who are at elevated risk for pregnancy complications but often afraid to seek medical care, has been awarded a National Academy of Medicine Catalyst Prize.